Caribou Biosciences, Inc. Income Tax Expense
Caribou Biosciences, Inc. (CRBU) reported Income Tax Expense of $0 for the 3-month period ending 2026-03-31, per its 10-Q filed 2026-05-07.
Financial Statements › Expense Statement › Income Tax
us-gaap:IncomeTaxExpenseBenefit · last filed 2026-05-07
- Caribou Biosciences, Inc. income tax expense (benefit) for the quarter ending 2026-03-31 was $0.00.
- Caribou Biosciences, Inc. income tax expense (benefit) for the quarter ending 2025-12-31 was -$550.00K.
- Caribou Biosciences, Inc. income tax expense (benefit) for the quarter ending 2025-09-30 was $0.00.
- Caribou Biosciences, Inc. income tax expense (benefit) for the quarter ending 2025-06-30 was $0.00.
- Caribou Biosciences, Inc. income tax expense (benefit) for fiscal 2025 was -$550.00K.
- Caribou Biosciences, Inc. income tax expense (benefit) for fiscal 2024 was -$9.00K, a 104.66% decline from fiscal 2023.
- Caribou Biosciences, Inc. income tax expense (benefit) for fiscal 2023 was $193.00K, a 175.71% increase from fiscal 2022.
- Caribou Biosciences, Inc. income tax expense (benefit) for fiscal 2022 was $70.00K, a 78.19% decline from fiscal 2021.
| Period end | Income Tax Expense (Benefit) 3 month | Income Tax Expense (Benefit) 3 month as first filed | Income Tax Expense (Benefit) 6 month | Income Tax Expense (Benefit) 9 month | Income Tax Expense (Benefit) 12 month |
|---|---|---|---|---|---|
| 2026-03-31 | $0.00 10-Q · filed 2026-05-07 | -$550.00K derived: sum of 2 quarters · filed 2026-05-07 | -$550.00K derived: sum of 3 quarters · filed 2026-05-07 | -$550.00K derived: sum of 4 quarters · filed 2026-05-07 | |
| 2025-12-31 | -$550.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-05 | -$550.00K derived: sum of 2 quarters · filed 2026-03-05 | -$550.00K derived: sum of 3 quarters · filed 2026-03-05 | -$550.00K 10-K · filed 2026-03-05 | |
| 2025-09-30 | $0.00 10-Q · filed 2025-11-12 | $0.00 derived: sum of 2 quarters · filed 2026-03-05 | $0.00 10-Q · filed 2025-11-12 | -$9.00K derived: sum of 4 quarters · filed 2026-03-05 | |
| 2025-06-30 | $0.00 derived: 10-K 12 month − 3 quarters · filed 2026-03-05 | $0.00 derived: sum of 2 quarters · filed 2026-03-05 | -$9.00K derived: sum of 3 quarters · filed 2026-03-05 | -$9.00K derived: sum of 4 quarters · filed 2026-03-05 | |
| 2025-03-31 | $0.00 10-Q · filed 2025-05-08 | -$9.00K derived: sum of 2 quarters · filed 2026-03-05 | -$9.00K derived: sum of 3 quarters · filed 2026-03-05 | -$9.00K derived: sum of 4 quarters · filed 2026-03-05 | |
| 2024-12-31 | -$9.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-05 | -$9.00K derived: sum of 2 quarters · filed 2026-03-05 | -$9.00K derived: sum of 3 quarters · filed 2026-03-05 | -$9.00K 10-K · filed 2026-03-05 | |
| 2024-09-30 | $0.00 10-Q · filed 2024-11-06 | $0.00 derived: sum of 2 quarters · filed 2024-11-06 | $0.00 10-Q · filed 2024-11-06 | $193.00K derived: sum of 4 quarters · filed 2025-05-08 | |
| 2024-06-30 | $0.00 10-Q · filed 2024-08-06 | $0.00 10-Q · filed 2024-08-06 | $193.00K derived: sum of 3 quarters · filed 2025-05-08 | $193.00K derived: sum of 4 quarters · filed 2025-05-08 | |
| 2024-03-31 | $0.00 10-Q · filed 2025-05-08 | $193.00K derived: sum of 2 quarters · filed 2025-05-08 | $193.00K derived: sum of 3 quarters · filed 2025-05-08 | $193.00K derived: sum of 4 quarters · filed 2025-05-08 | |
| 2023-12-31 | $193.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-10 | $193.00K derived: sum of 2 quarters · filed 2025-03-10 | $193.00K derived: sum of 3 quarters · filed 2025-03-10 | $193.00K 10-K · filed 2025-03-10 | |
| 2023-09-30 | $0.00 10-Q · filed 2024-11-06 | $0.00 derived: sum of 2 quarters · filed 2024-11-06 | $0.00 10-Q · filed 2024-11-06 | $70.00K derived: sum of 4 quarters · filed 2024-11-06 | |
| 2023-06-30 | $0.00 10-Q · filed 2024-08-06 | $0.00 10-Q · filed 2024-08-06 | $70.00K derived: sum of 3 quarters · filed 2024-08-06 | $70.00K derived: sum of 4 quarters · filed 2024-08-06 | |
| 2023-03-31 | $0.00 10-Q · filed 2024-05-07 | $70.00K derived: sum of 2 quarters · filed 2024-05-07 | $70.00K derived: sum of 3 quarters · filed 2024-05-07 | $70.00K derived: sum of 4 quarters · filed 2024-05-07 | |
| 2022-12-31 | $70.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-11 | $70.00K derived: sum of 2 quarters · filed 2024-03-11 | $70.00K derived: sum of 3 quarters · filed 2024-03-11 | $70.00K 10-K · filed 2024-03-11 | |
| 2022-09-30 | $0.00 10-Q · filed 2023-11-07 | $0.00 derived: sum of 2 quarters · filed 2023-11-07 | $0.00 10-Q · filed 2023-11-07 | $321.00K derived: sum of 4 quarters · filed 2023-11-07 | |
| 2022-06-30 | $0.00 10-Q · filed 2023-08-08 | $0.00 10-Q · filed 2023-08-08 | $321.00K derived: sum of 3 quarters · filed 2023-08-08 | $321.00K derived: sum of 4 quarters · filed 2023-08-08 | |
| 2022-03-31 | $0.00 10-Q · filed 2023-05-09 | $321.00K derived: sum of 2 quarters · filed 2023-05-09 | $321.00K derived: sum of 3 quarters · filed 2023-05-09 | $321.00K derived: sum of 4 quarters · filed 2023-05-09 | |
| 2021-12-31 | $321.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-09 | $321.00K derived: sum of 2 quarters · filed 2023-03-09 | $321.00K derived: sum of 3 quarters · filed 2023-03-09 | $321.00K 10-K · filed 2023-03-09 | |
| 2021-09-30 | $0.00 10-Q · filed 2022-11-08 | $0.00 derived: sum of 2 quarters · filed 2022-11-08 | $0.00 10-Q · filed 2022-11-08 | -$354.00K derived: sum of 4 quarters · filed 2022-11-08 | |
| 2021-06-30 | $0.00 10-Q · filed 2022-08-09 | $0.00 10-Q · filed 2022-08-09 | -$354.00K derived: sum of 3 quarters · filed 2022-08-09 | -$567.00K derived: sum of 4 quarters · filed 2022-08-09 | |
| 2021-03-31 | $0.00 10-Q · filed 2022-05-09 | -$354.00K derived: sum of 2 quarters · filed 2022-05-09 | -$567.00K derived: sum of 3 quarters · filed 2022-05-09 | -$617.00K derived: sum of 4 quarters · filed 2022-05-09 | |
| 2020-12-31 | -$354.00K 10-K · filed 2022-03-21 | -$567.00K derived: sum of 2 quarters · filed 2022-03-21 | -$617.00K derived: sum of 3 quarters · filed 2022-03-21 | -$1.82M 10-K · filed 2022-03-21 | |
| 2020-09-30 | -$213.00K 10-K · filed 2022-03-21 | $213.00K 10-Q · filed 2021-11-09 | -$263.00K derived: sum of 2 quarters · filed 2022-03-21 | $1.47M 10-Q · filed 2021-11-09 | |
| 2020-06-30 | -$50.00K 10-K · filed 2022-03-21 | -$1.25M 10-Q · filed 2021-09-02 | |||
| 2020-03-31 | -$1.20M 10-K · filed 2022-03-21 | ||||
| 2019-12-31 | -$7.54M 10-K · filed 2022-03-21 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Armata Pharmaceuticals, Inc. (ARMP) | United States | $0.132B | |
| Neumora Therapeutics, Inc. (NMRA) | United States | $0.132B | -1.48 |
| enGene Therapeutics Inc. (ENGN) | $0.129B | -0.92 | |
| Tenaya Therapeutics, Inc. (TNYA) | United States | $0.140B | -1.60 |
| LENZ Therapeutics, Inc. (LENZ) | United States | $0.117B | -1.41 |
| Humacyte, Inc. (HUMA) | United States | $0.155B | -2.26 |
| Black Diamond Therapeutics, Inc. (BDTX) | United States | $0.109B | -2.48 |
| Outlook Therapeutics, Inc. (OTLK) | United States | $0.162B | -4.90 |
| Acumen Pharmaceuticals, Inc. (ABOS) | United States | $0.162B | -1.83 |
| Cardiff Oncology, Inc. (CRDF) | United States | $0.101B | -2.22 |